Cite
MLA Citation
Oana D. Persa et al.. “Risk Factors for Relapse after Intentional Discontinuation of Immune Checkpoint Inhibitors in Melanoma Patients.” Journal of immunotherapy, vol. 44, no. 6, 2021, pp. 239–241. http://access.bl.uk/ark:/81055/vdc_100145632216.0x000018